
Cathay Capital backs Minafin
French-Chinese investor Cathay Capital has taken a minority stake in French chemicals manufacturer Minafin.
The transaction is valued in Cathay's usual €5-15m investment range. The GP invested via the Cathay Capital II fund, which held a first close on €125m in May. The GP's focus on China will help Minafin strengthen its execution capability in the country.
The investment will also back Minafin's acqusition strategy. The group was notably looking at a potential merger with Gilde-backed Novasep recently – the latter has, however, just been through a capital restructuring instead.
Company
Minafin was established in 2005 as a spinout of chemical company SEAC. It specialises in fine chemicals, advanced cosmetology, pharmaceutical intermediates and active pharmaceutical ingredients.
Operating across four manufacturing sites in France, Germany and the US, the group generates revenues of €120m. It employs around 580 people.
People
Anne-Sophie Roquette led the deal for Cathay. Frédéric Gauchet is CEO of Minafin.
Advisers
Equity – BMA, Hervé Krissi (Financial due diligence); ACDR, Cyril Facchin (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater